End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients

Table 3 In-hospital complications after endoscopic retrograde cholangiopancreatography from 2011 to 2013 based on data from the Nationwide Inpatient Sample comparing chronic kidney disease to controls n (%)

Type of complications	CKDn = 39403	Controln = 445424	CrudeOR/MD (95%CI)	AdjustedOR/MD (95%CI)	AdjustedP value
Death	1176 (3)	5138 (1.15)	2.6 (2.3-3.0)	1.3 (1.14-1.55)	0.001
Pancreatitis	750 (6.8)	20315 (4.6)	1.5 (1.3-1.6)	1.5 (1.3-1.7)	< 0.001
Bleeding	1454 (3.7)	6546 (1.5)	2.56 (2.25–2.90)	1.4 (1.2-1.6)	< 0.001
Perforation	43 (0.1)	340 (0.07)	1.4 (0.7–2.9)	1.36 (0.6–3.2)	0.5
Length of hospital stay, mean days (SE)	8.5 (0.11)	6 (0.03)	2.45 (2.24-2.67)	1.4 (1.20-1.65)	< 0.001

CKD: Chronic kidney disease; OR: Odd ratio; MD: Mean difference.